Skip to content

Secondary preventive, nurse based, telephone follow-up for reduction of cardiovascular events after acute coronary syndrome or stroke

Secondary preventive, nurse based, telephone follow-up for reduction of cardiovascular events after acute coronary syndrome or stroke: a randomised, controlled, population based study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN30433343
Enrollment
1900
Registered
2015-01-26
Start date
2010-01-01
Completion date
Unknown
Last updated
2025-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute coronary syndrome, stroke and transient ischemic attack Circulatory System

Interventions

A study nurse will contact patients randomised to the intervention group by phone 1 month after discharge. Before the call a blood sample for lipids will be taken and a standardised blood pressure con

Sponsors

Jamtland County Council (Sweden)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. All patients living in the county of Jämtland, Sweden, and hospitalised with a diagnosis of an acute coronary syndrome (ACS, acute myocardial infarction or unstable angina pectoris), stroke (ischemic or hemorrhagic) or transient ischemic attack (TIA) will be assessed for inclusion 1.1. Östersund hospital is the only hospital in the county and all patients, terminal care excluded, with symptoms of an ACS or suspected stroke or TIA are referred for diagnostic evaluation. A routine for identification of all patients in the hospital with a possible ACS or stroke/TIA has been established in previous studies. 2. All patients with a physical and mental capacity to communicate by telephone

Exclusion criteria

Exclusion criteria: 1. Patients with severe disease 2. Aphasia 3. Dementia 4. Deafness 5. Participation in another trial

Design outcomes

Primary

MeasureTime frame
Major adverse cardiovascular events identified at the end of trial by reviewing patients medical records and by the Swedish National Patient Register and the Swedish Cause of Death Register defined as: 1. Non-fatal major coronary event: myocardial infarction or coronary revascularisation 2. Non-fatal stroke 3. Cardiovascular death

Secondary

MeasureTime frame
Major adverse cardiovascular events identified at the end of trial by reviewing patients medical records and by the Swedish National Patient Register and the Swedish Cause of Death Register. 1. Separate assessment of the individual components of the primary endpoint 2. Transient ischemic attack 3. All-cause mortality 4. Separate assessment of the acute coronary syndrome and the stroke / TIA cohorts

Countries

Sweden

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 21, 2026